Alfacalcidol



Indications and Reactions:

Role Indications Reactions
Primary
Dementia Alzheimer's Type 50.0%
Hyperparathyroidism Secondary 50.0%
Electrocardiogram Qt Interval Abnormal 50.0%
Proteinuria 50.0%
Secondary
Product Used For Unknown Indication 30.6%
Drug Use For Unknown Indication 14.7%
Hypertension 9.1%
Prophylaxis 6.9%
Osteoporosis 6.7%
Multiple Myeloma 5.8%
Rheumatoid Arthritis 4.9%
Hypoparathyroidism 3.7%
Diuretic Therapy 3.4%
Juvenile Arthritis 2.2%
Gastritis 1.9%
Hyperparathyroidism Secondary 1.7%
Behcet's Syndrome 1.3%
Anaemia 1.1%
Cardiac Failure Chronic 1.1%
Congestive Cardiomyopathy 1.1%
Osteoporosis Prophylaxis 1.1%
Prophylaxis Urinary Tract Infection 1.1%
Constipation 0.7%
Femur Fracture 0.7%
Dehydration 12.2%
Visual Acuity Reduced 12.2%
Liver Disorder 10.8%
Renal Failure 9.5%
Rash Papular 6.8%
Follicular Mucinosis 4.1%
Hydronephrosis 4.1%
Hypercalcaemia 4.1%
Milk-alkali Syndrome 4.1%
Optic Disc Disorder 4.1%
Prothrombin Time Abnormal 4.1%
Calciphylaxis 2.7%
Colitis Collagenous 2.7%
Convulsion 2.7%
Diarrhoea 2.7%
Electrocardiogram Qt Prolonged 2.7%
Hypokalaemia 2.7%
Intracranial Pressure Increased 2.7%
Premature Delivery 2.7%
Rhabdomyolysis 2.7%
Concomitant
Rheumatoid Arthritis 22.3%
Product Used For Unknown Indication 22.2%
Drug Use For Unknown Indication 15.1%
Osteoporosis 7.3%
Hypertension 6.9%
Prophylaxis 6.9%
Diabetes Mellitus 1.7%
Hyperparathyroidism Secondary 1.6%
Osteoporosis Prophylaxis 1.6%
Renal Failure 1.5%
Gastritis Prophylaxis 1.5%
Antibiotic Prophylaxis 1.5%
Insomnia 1.4%
Renal Transplant 1.4%
Adverse Drug Reaction 1.3%
Constipation 1.3%
Gastritis 1.2%
Renal Failure Chronic 1.2%
Crohn's Disease 1.1%
Anaemia 1.1%
Vomiting 11.7%
Rhabdomyolysis 9.9%
Pyrexia 9.7%
Urinary Tract Infection 6.1%
Death 5.3%
Pneumonia 5.3%
Renal Failure 5.3%
Renal Failure Acute 5.3%
Therapeutic Response Decreased 5.0%
Tremor 4.0%
Hypocalcaemia 3.6%
Interstitial Lung Disease 3.6%
Tetany 3.6%
Proteinuria 3.4%
Renal Failure Chronic 3.2%
Renal Impairment 3.2%
Rheumatoid Arthritis 3.2%
Peritonitis 3.0%
Urticaria 3.0%
Hypoglycaemia 2.8%
Interacting
Hypertension 53.8%
Drug Use For Unknown Indication 23.1%
Product Used For Unknown Indication 15.4%
Cerebral Infarction 7.7%
Hyperkalaemia 40.0%
Dehydration 20.0%
Hepatocellular Damage 20.0%
Hypercalcaemia 20.0%